← Evidence map

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of a Phase I Study.

Jifeng Feng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

42 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35653122